EUVIMEDEUVIMED entdecken
Crossref

Specific reversal agents in acute stroke

Senta Frol

Rad Hrvatske akademije znanosti i umjetnosti. Medicinske znanosti · 2024

DOI: 10.21857/9e31lhzpkm ↗

Kurz gefasst

Fachartikel in der Zeitschrift Rad Hrvatske akademije znanosti i umjetnosti. Medicinske znanosti, 2024. Verfasst von Senta Frol.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Direct oral anticoagulants (DOACs) are first line therapy in primary and secondary stroke prevention in patients with non-valvular atrial fibrillation.Regardless of their use a minority of patients still suffer acute stroke (ischemic or hemorrhagic).Specific reversal agents changed concept of therapy in DOACtreated patients with acute stroke.In this manuscript data on randomized controlled trials, real-world evidence and proposed standard operating procedures are summarized.

Zitieren

APA

Frol, S. (2024). Specific reversal agents in acute stroke. Rad Hrvatske akademije znanosti i umjetnosti. Medicinske znanosti. https://doi.org/10.21857/9e31lhzpkm

Vancouver

Frol S. Specific reversal agents in acute stroke. Rad Hrvatske akademije znanosti i umjetnosti. Medicinske znanosti. 2024. doi:10.21857/9e31lhzpkm

BibTeX
@article{Frol2024,
  author = {Frol, Senta},
  title = {Specific reversal agents in acute stroke},
  journal = {Rad Hrvatske akademije znanosti i umjetnosti. Medicinske znanosti},
  year = {2024},
  doi = {10.21857/9e31lhzpkm}
}
Kostenlos starten →